Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19.

JAAD Case Rep

Michigan Medicine Department of Dermatology, Ann Arbor, Michigan.

Published: September 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273519PMC
http://dx.doi.org/10.1016/j.jdcr.2022.07.007DOI Listing

Publication Analysis

Top Keywords

annular lichenoid
4
lichenoid eruption
4
eruption treatment
4
treatment casirivimab/imdevimab
4
casirivimab/imdevimab covid-19
4
annular
1
eruption
1
treatment
1
casirivimab/imdevimab
1
covid-19
1

Similar Publications

A healthy 14-year-old boy presented with a 2-month history of two slowly expanding asymptomatic lesions on his right trunk. No etymology of any new medications, recent travel, or tick bites was reported. Physical examination demonstrated two 4.

View Article and Find Full Text PDF

Pigmented actinic lichen planus: a case report.

Acta Dermatovenerol Alp Pannonica Adriat

September 2024

Clinic of Dermatology and Venereology, University Clinical Center of Serbia, Belgrade, Serbia.

Article Synopsis
  • Actinic lichen planus (ALP) is a rare and photosensitive form of lichen planus, most common in younger dark-skinned females from warmer regions, with four recognized types including pigmented and classic forms.
  • A case study describes a 68-year-old white man with a 9-year history of a mildly itchy hyperpigmented patch on his nose, ultimately diagnosed as pigmented ALP through histopathological analysis showing characteristic changes.
  • Treatment involved topical pimecrolimus and tretinoin, effective in reducing symptoms, while emphasizing the importance of accurate diagnosis and ongoing sun protection to manage and prevent the condition.
View Article and Find Full Text PDF

Many faces of cutaneous leishmaniasis.

Postgrad Med J

September 2024

Department of Medical Microbiology, Harran University Medical Faculty, Şanlıurfa 63000, Turkey.

Article Synopsis
  • This study aimed to identify atypical clinical presentations of cutaneous leishmaniasis (CL) in Şanlıurfa province, encompassing a retrospective analysis of 213 patients with non-standard symptoms out of 1,751 diagnosed cases between 2019 and 2022.
  • The prevalence of atypical CL was found to be 12.1%, with common atypical lesions including lupoid, erysipeloid, and impetiginous types, along with many others resembling various skin conditions and diseases.
  • The research highlights that CL can mimic a wide range of infectious, inflammatory, and neoplastic disorders, stressing the importance of thorough differential diagnosis for persistent non-healing skin lesions, especially in areas where CL is
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!